Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ginseng for Cancer-Related Fatigue in Survivors
NCT03407716Phase 1Completed
- Sponsor
- Mayo Clinic
- Start
- Mar 2019
- Primary completion
- May 2020
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of panax quinquefolius in cancer-related fatigue (CRF) (2 arms), sponsored by Mayo Clinic. Primary endpoint: Multidimensional Fatigue Symptom Inventory-Short Form General Subscale at 56 days. Started Mar 2019; status: completed.
02
Drugs
panax quinquefolius
03
Conditions
cancer-related fatigue (CRF)
Beyond the preview
Go deeper on NCT03407716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03407716.